FarmaKology Newsletter - Issue #5
Validic is the healthcare industry’s premier technology platform for convenient, easy access to digital health data from best-in-class clinical and remote-monitoring devices, sensors, fitness equipment, wearables and patient wellness applications. Validic’s mission continues to be helping our healthcare clients and integrations thrive in this transformational industry.
Ra Pharmaceuticals Announces Completion of End-of-Phase 2 Interactions with FDA and Design of Pivotal Phase 3 gMG Study
Ra Pharmaceuticals, Inc.today announced the successful completion of End-of-Phase 2 interactions with the U.S. Food and Drug Administration (FDA) for its Phase 3 clinical trial of zilucoplan for the treatment of generalized myasthenia gravis (gMG).
Unrivalled imaging capabilities now available to accelerate UK drug development
Medicines Discovery Catapult integrates Alderley Park’s imaging services and expertise, further enhancing preclinical imaging capabilities.
ReNeuron Partners with Fosun Pharma in China
ReNeuron Group plc , a UK-based global leader in the development of cell-based therapeutics, is pleased to announce that it has signed an exclusive licence agreement with Shanghai Fosun Pharmaceutical Industrial Development Co.
FDA takes major step to lower insulin prices
FDA explained that this transition will allow biosimilar insulin products and substitutes to come to market for the first time, stimulating competition and hopefully lowering the drug’s prices.
Anti-inflammatory medicine can have a beneficial effect on depression
Dermatologists prescribe more oral antibiotics after surgical procedures
New drugs developed to treat ovarian cancer
Stream Episode 61 - A Pharmacist in Health Informatics by Rx Radio: Pharmacy's Podcast from desktop or your mobile device